Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Lin, Enmoore ^a   Kiniboro, Benson ^a   Gray, Laurie ^b   Dobbie, Stuart ^a   Robinson, Leanne ^c,d   Laumaea, Annemarie ^a   Schöpflin, Sonja ^e   Stanisic, Danielle ^a,c   Betuela, Inoni ^a   Blood Zikursh, Melinda ^b   Siba, Peter ^a   Felger, Ingrid ^e   Schofield, Louis ^c   Zimmerman, Peter ^b   Mueller, Ivo ^a  

^a PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; FOLIC ACID; IRON; PYROGEN;

AGE DISTRIBUTION; ANEMIA; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DENSITY; DISEASE DURATION; EXPOSURE; FEMALE; FEVER; FOLLOW UP; HUMAN; IMMUNITY; INCIDENCE; INFANT; INFECTION RISK; LIVER; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MICROSCOPY; PAPUA NEW GUINEA; PARASITE; PERINEUM; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; RELAPSE; SEASONAL VARIATION; AGE; BED NET; CROSS-SECTIONAL STUDY; ENDEMIC DISEASE; GENETICS; GEOGRAPHY; ISOLATION AND PURIFICATION; MONONUCLEAR CELL; MULTIVARIATE ANALYSIS; PARASITOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SEASON;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

AGE FACTORS; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENDEMIC DISEASES; FOLLOW-UP STUDIES; GEOGRAPHY; HUMANS; INCIDENCE; INFANT; INSECTICIDE-TREATED BEDNETS; LEUKOCYTES, MONONUCLEAR; MALARIA, FALCIPARUM; MALARIA, VIVAX; MULTIVARIATE ANALYSIS; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PREVALENCE; SEASONS;

EID: 77949350551     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009047     Document Type: Article

References (50)

1. Marsh K, Kinyanjui S (2006) Immune effector mechanisms in malaria. Parasite Immunol 28: 51-60.
2. Gupta S, Snow RW, Donnelly CA,Marsh K, Newbold C (1999) Immunity to noncerebral severe malaria is acquired after one or two infections. Nat Med 5: 340-343.
3. Genton B, Al Yaman F, Beck HP, Hii J, Mellor S, et al. (1995) The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity. Ann Trop Med Parasitol 89: 359-376.
4. Genton B, Al Yaman F, Beck HP, Hii J, Mellor S, et al. (1995) The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity. Ann Trop Med Parasitol 89: 377-390.
5. Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, et al. (2007) The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg 76: 997-1008.
6. Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, et al. (2008) Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 5: e127.
7. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, et al. (2008) Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 5: e128.
8. Smith T, Hii JL, Genton B, Muller I, Booth M, et al. (2001) Associations of peak shifts in age - prevalence for human malarias with bednet coverage. Trans R Soc Trop Med Hyg 95: 1-6.
9. Kasehagen LJ, Mueller I, McNamara DT, Bockarie MJ, Kiniboro B, et al. (2006) Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis. Am J Trop Med Hyg 75: 588-596.
10. Mueller I, Widmer S, Michel D, Maraga S, McNamara DT, et al. (2009) High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea. Malar J 8: 41.
11. Cox MJ, Kum DE, Tavul L, Narara A, Raiko A, et al. (1994) Dynamics of malaria parasitaemia associated with febrile illness in children from a rural area of Madang, Papua New Guinea. TransRSocTropMedHyg 88: 191-197.
12. Maitland K, Williams TN, Bennett S, Newbold CI, Peto TE, et al. (1996) The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg 90: 614-620.
13. Balfour MC (1935) Malaria studies in Greece. Am J Trop Med Hyg 15: 301-329.
14. Earle WC (1939) Epidemiology of malaria in Puerto Rico. Puerto Rico J Pub Health Trop Med 15: 3-27.
15. Ciuca M, Ballif L, Chelarescu-VieruM(1934) Immunity in Malaria. Trans R Soc Trop Med Hyg 6: 619-622.
16. Collins WE, Jeffery GM, Roberts JM (2004) A retrospective examination of reinfection of humans with Plasmodium vivax. Am J Trop Med Hyg 70: 642-644.
17. Collins WE, Jeffery GM (1999) A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am J Trop Med Hyg 61: 20-35.
18. Gunewardena DM, Carter R, Mendis KN (1994) Patterns of acquired antimalarial immunity in Sri Lanka. Mem Inst Oswaldo Cruz 89: 63-65.
19. Schofield L, Mueller I (2006) Clinical immunity to malaria. Curr Mol Med 6: 205-221.
20. Yazdani SS, Mukherjee P, Chauhan VS, Chitnis CE (2006) Immune responses to asexual blood-stages of malaria parasites. Curr Mol Med 6: 187-203.
21. Wipasa J, Elliott S, Xu H, Good MF (2002) Immunity to asexual blood stage malaria and vaccine approaches. Immunol Cell Biol 80: 401-414.
22. Bull PC, Marsh K (2002) The role of antibodies to Plasmodium falciparum-infectederythrocyte surface antigens in naturally acquired immunity to malaria. Trends Microbiol 10: 55-58.
23. Arevalo-Herrera M, Herrera S (2001) Plasmodium vivax malaria vaccine development. Mol Immunol 38: 443-455.
24. Cole-Tobian JL, Cortes A, Baisor M, Kastens W, Xainli J, et al. (2002) Ageacquired immunity to a Plasmodium vivax invasion ligand, the duffy binding protein. J Infect Dis 186: 531-539.
25. Michon P, Fraser T, Adams JH (2000) Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect Immun 68: 3164-3171.
26. King CL, Michon P, Shakri AR, Marcotty A, Stanisic D, et al. (2008) Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci U S A 105: 8363-8368.
27. Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, et al. (2009) Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun 77: 1165-1174.
28. D'Ombrain MC, Robinson LJ, Stanisic DI, Taraika J, Bernard N, et al. (2008) Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. Clin Infect Dis 47: 1380-1387.
29. Robinson LJ, D'Ombrain MC, Stanisic DI, Taraika J, Bernard N, et al. (2009) Cellular TNF, IFN-γ and IL-6 responses: correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect Immun 77: 3033-3043.
30. McNamara DT, Kasehagen LJ, Grimberg BT, Cole-Tobian J, Collins WE, et al. (2006) Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microspherebased assay. Am J Trop Med Hyg 74: 413-421.
31. McNamara DT, Thomson JM, Kasehagen LJ, Zimmerman PA (2004) Development of a multiplex PCR-ligase detection reaction assay for diagnosis of infection by four human malaria parasite species. J Clin Microbol 42: 2403-2410.
32. Müller I, Genton B, Rare L, Kiniboro B, Kastens W, et al. Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection. Malar J. (in press).
33. Phimpraphi W, Paul RE, Yimsamran S, Puangsa-art S, Thanyavanich N, et al. (2008) Longitudinal study of Plasmodium falciparum and Plasmodium vivax in a Karen population in Thailand. Malar J 7: 99.
34. Luxemburger C, Thwai KL, White NJ, Webster HK, Kyle DE, et al. (1996) The epidemiology of malaria in a Karen population on the western border of Thailand. Trans R Soc Trop Med Hyg 90: 105-111.
35. Mendis K, Sina BJ, Marchesini P, Carter R (2001) The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97-106.
36. Collins WE, Jeffery GM, Roberts JM (2004) A retrospective examination of the effect of fever and microgametocyte count on mosquito infection on humans infected with Plasmodium vivax. Am J Trop Med Hyg 70: 638-641.
37. Graves PM, Burkot TR, Carter R, Cattani JA, Lagog M, et al. (1988) Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua, New Guinea. Parasitology 96 (Pt 2): 251-263.
38. Bockarie MJ, Alexander N, Bockarie F, Ibam E, Barnish G, et al. (1996) The late biting habit of parous Anopheles mosquitoes and pre-bedtime exposure of humans to infective female mosquitoes. TransRSocTropMedHyg 90: 23-25.
39. Bockarie MJ, Dagoro H (2006) Are insecticide-treated bednets more protective against Plasmodium falciparum than Plasmodium vivax-infected mosquitoes? Malar J 5: 15.
40. Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, et al. (2008) A trial of combination antimalarial therapies in children from Papua New Guinea. N Engl J Med 359: 2545-2557.
41. Lengeler C (2004) Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev 2: CD000363.
42. Luxemburger C, Perea WA, Delmas G, Pruja C, Pecoul B, et al. (1994) Permethrin-impregnated bed nets for the prevention of malaria in schoolchildren on the Thai-Burmese border. Trans R Soc Trop Med Hyg 88: 155-159.
43. Muller I, Smith T, Mellor S, Rare L, Genton B (1998) The effect of distance from home on attendance at a small rural health centre in Papua New Guinea. Int J Epidemiol 27: 878-884.
44. Muller O, Traore C, Becher H, Kouyate B (2003) Malaria morbidity, treatmentseeking behaviour, and mortality in a cohort of young children in rural Burkina Faso. Trop Med Int Health 8: 290-296.
45. Beeson JG, Brown GV (2002) Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation. Cell Mol Life Sci 59: 258-271.
46. Craig A, Scherf A (2001) Molecules on the surface of the Plasmodium falciparum infected erythrocyte and their role in malaria pathogenesis and immune evasion. Mol Biochem Parasitol 115: 129-143.
47. Vestergaard LS, Lusingu JP, Nielsen MA, Mmbando BP, Dodoo D, et al. (2008) Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in northeastern Tanzania. Infect Immun 76: 2706-2714.
48. Scherf A, Lopez-Rubio JJ, Riviere L (2008) Antigenic variation in Plasmodium falciparum. Annu Rev Microbiol 62: 445-470.
49. Fernandez-Becerra C, Yamamoto MM, Vencio RZ, Lacerda M, Rosanas-Urgell A, et al. (2009) Plasmodium vivax and the importance of the subtelomeric multigene vir superfamily. Trends Parasitol 25: 44-51.
50. Cowman AF, Crabb BS (2006) Invasion of red blood cells by malaria parasites. Cell 124: 755-766.